
As a former Dean and appointed University Professor and Endowed Department Chair, Dr. David Edward Marcinko MBA was a NYSE broker and investment banker for a decade who was respected for his unique perspectives, balanced contrarian thinking and measured judgment to influence key decision makers in strategic education, health economics, finance, investing and public policy management.
Dr. Marcinko is originally from Loyola University MD, Temple University in Philadelphia and the Milton S. Hershey Medical Center in PA; as well as Oglethorpe University and Emory University in Georgia, the Atlanta Hospital & Medical Center; Kellogg-Keller Graduate School of Business and Management in Chicago, and the Aachen City University Hospital, Koln-Germany. He became one of the most innovative global thought leaders in medical business entrepreneurship today by leveraging and adding value with strategies to grow revenues and EBITDA while reducing non-essential expenditures and improving dated operational in-efficiencies.
Professor David Marcinko was a board certified surgical fellow, hospital medical staff President, public and population health advocate, and Chief Executive & Education Officer with more than 425 published papers; 5,150 op-ed pieces and over 135+ domestic / international presentations to his credit; including the top ten [10] biggest drug, DME and pharmaceutical companies and financial services firms in the nation. He is also a best-selling Amazon author with 30 published academic text books in four languages [National Institute of Health, Library of Congress and Library of Medicine].
Dr. David E. Marcinko is past Editor-in-Chief of the prestigious “Journal of Health Care Finance”, and a former Certified Financial Planner® who was named “Health Economist of the Year” in 2010. He is a Federal and State court approved expert witness featured in hundreds of peer reviewed medical, business, economics trade journals and publications [AMA, ADA, APMA, AAOS, Physicians Practice, Investment Advisor, Physician’s Money Digest and MD News] etc.
Later, Dr. Marcinko was a vital and recruited BOD member of several innovative companies like Physicians Nexus, First Global Financial Advisors and the Physician Services Group Inc; as well as mentor and coach for Deloitte-Touche and other start-up firms in Silicon Valley, CA.
As a state licensed life, P&C and health insurance agent; and dual SEC registered investment advisor and representative, Marcinko was Founding Dean of the fiduciary and niche focused CERTIFIED MEDICAL PLANNER® chartered professional designation education program; as well as Chief Editor of the three print format HEALTH DICTIONARY SERIES® and online Wiki Project.
Dr. David E. Marcinko’s professional memberships included: ASHE, AHIMA, ACHE, ACME, ACPE, MGMA, FMMA, FPA and HIMSS. He was a MSFT Beta tester, Google Scholar, “H” Index favorite and one of LinkedIn’s “Top Cited Voices”.
Marcinko is “ex-officio” and R&D Scholar-on-Sabbatical for iMBA, Inc. who was recently appointed to the MedBlob® [military encrypted medical data warehouse and health information exchange] Advisory Board.


4 in 10 Seniors Have Not Documented End-of-Life Care Wishes
Kaiser Family Foundation recently released an infographic on Medicare and end-of-life care. Here are some key findings from the report:
• Of the 2.6 million deaths in 2014, 2.1 million were Medicare beneficiaries.
• The share of Medicare spending for end-of-life care was 13.5% in 2014.
• Medicare spent $34,529 per beneficiary for people who died in 2014.
• Medicare spending on hospice rose from $2.3 bil. in 2000 to $10.4 bil. in 2014.
• 70% of people over age 65 have not discussed end-of-life care with a physician.
• 4 in 10 people over age 65 have not documented their end-of-life care wishes.
Source: Kaiser Family Foundation, November 1, 2016
LikeLike
Inside Google’s Plan to Lengthen Life
The quest to slow aging is tantalizing, complex—and divisive. With $1.5 billion in the bank, Google’s spinout Calico is taking its own distinctive approach to the problem.
MIT Technology Review’s Antonio Regalado finds that the secretive company is, in effect, an elite university research group housed within a corporate bunker, doing mostly basic science. The company is studying yeast, worms, and even naked mole rats to find out how to help you live longer. “We believe you have to take a very long view,” says Calico’s Hal Barron, “and not rush into the clinic.”
Not everyone agrees. Aubrey de Grey, a proponent of interventions to slow aging, says Calico is built on “the assumption that we still do not understand aging well enough … to develop therapies.”
Some researchers are trying to develop interventions as quickly as possible, though—such as those from the Salk Institute, who yesterday announced that a new kind of gene therapy could rejuvenate mice. It remains to be seen which approach is best.
But, as Regalado points out, Calcio’s large bank balance will come in useful for finding out.
MIT Technology Review
LikeLike
More on euthanasia
Elderly couple got ‘deepest wish’ — to die together — in rare euthanasia case.
http://www.msn.com/en-us/news/world/elderly-couple-got-%e2%80%98deepest-wish%e2%80%99-%e2%80%94-to-die-together-%e2%80%94-in-rare-euthanasia-case/ar-AAqg1Uc?li=BBnbfcL
Dr. David Marcinko MBA
LikeLike
Virtual reality death simulator could ‘cure society’s fear of dying’
Scientists use headsets to stimulate the feeling of passing away and leaving your body
https://www.thesun.co.uk/news/2694271/virtual-reality-death-simulator-could-cure-societys-fear-of-dying/
Dr. David Marcinko MBA
LikeLike